New York, NY 28 Jan 2021: The global platelet aggregation devices market size is expected to reach USD 1,556.8 million by 2027 according to a new study by Polaris Market Research. The report “Platelet Aggregation Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Systems, Reagents, Consumables and Accessories); By Application (Research Applications, Clinical Applications, Others); By End Use (Standalone Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Blood Banks, and Other End Users); By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Platelet aggregation is the biological process where the platelet cells are employed in a process to prevent bleeding through vaso-constriction for rapid clot formation. The whole process is mediated via platelet aggregating factor (PAF). The quantitative and qualitative defects of platelets lead to increased bleeding. The high reactivity of platelets in the patients having anti-platelet therapy results in thromboembolic complications.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/platelet-aggregation-devices-market/request-for-sample
The market is driven by few notable factors such as the recent surge in infectious diseases (COVID-19) requiring rapid serological tests, innovations in platelet aggregation mechanisms, systems and consumables, and worldwide rise in chronic ailments. Specialized tests based on platelet aggregation include light transmission platelet aggregometry on platelet-rich plasma (LTA), impedance whole blood aggregometry (WBA), Lumi-aggregometry and flow cytometry.
Automated haematology analyzers can be used to obtain platelet counts over a wide range of values using optical counting methods like light scatter or fluorescence. Screening tests such as prothrombin time (PT) or activated partial thromboplastin time (aPTT) are more standardized and fully automated.
Number of reagents are available in the market to carry out the platelet function tests. These reagents include collagen, thrombin, ADP, vasopressin, epinephrine and ristocetin. Collagen, ADP were used in routine platelet aggregation studies for the evaluation of qualitative platelet function disorders.
To get Incredible Discounts on this Premium Report, Click At : https://www.polarismarketresearch.com/industry-analysis/platelet-aggregation-devices-market/request-for-discount-pricing
Market participants such as F. Hoffmann La-Roche Ltd., Drucker Diagnostics, Haemonetics Corporation, Sysmex Corporation, Siemens Healthineers, Chrono-log Corporation, Instrumentation Laboratory, Accriva Diagnostics, Matis Medical, Helena Laboratories Corporation, Sienco, Inc., Bio/Data Corporation, Tem Group, WerfenLife, S.A., Laboratory Corporation of America Holdings, Sentinel CH. S.p.A., and Aggredyne, Inc. are some of the key players operating in the concerned market.
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: [email protected]
"Trending News:Platelet Aggregation Devices Market Report is Booming Globally by Top Leading Players"The global platelet aggregation devices market size is expected to reach USD 1,556.8 million by 2027 according to a new study by Polaris Market Research.
Platelet aggregation is the biological process where the platelet cells are employed in a process to prevent bleeding through vaso-constriction for rapid clot formation.
The whole process is mediated via platelet aggregating factor (PAF).
The high reactivity of platelets in the patients having anti-platelet therapy results in thromboembolic complications.
The inherited platelet function disorders include Von Willebrand disease, Glanzmann’s thrombasthenia, Bernard-Soulier syndrome, Storage pool disease.
The acquired platelet dysfunction may be caused by chronic conditions such as kidney failure (uremia), Myelodysplastic syndrome (MDS), Leukemias (chronic myeloid leukemia or CML; acute myeloid leukemia or AML).
New York, NY 22 Oct 2021: The global platelet aggregation devices market size is expected to reach USD 1,556.8 million by 2027 according to a new study by Polaris Market Research.
The report “Platelet Aggregation Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Systems, Reagents, Consumables and Accessories); By Application (Research Applications, Clinical Applications, Others); By End Use (Standalone Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Blood Banks, and Other End Users); By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Platelet aggregation is the biological process where the platelet cells are employed in a process to prevent bleeding through vaso-constriction for rapid clot formation.
The whole process is mediated via platelet aggregating factor (PAF).
The high reactivity of platelets in the patients having anti-platelet therapy results in thromboembolic complications.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/platelet-aggregation-devices-market/request-for-sampleThe market is driven by few notable factors such as the recent surge in infectious diseases (COVID-19) requiring rapid serological tests, innovations in platelet aggregation mechanisms, systems and consumables, and worldwide rise in chronic ailments.
Automated haematology analyzers can be used to obtain platelet counts over a wide range of values using optical counting methods like light scatter or fluorescence.
Platelet Aggregation Devices Market Trends And Growth Analysis By Product (Systems, Reagents, Consumables And Accessories), Application (Clinical, Research Applications), End User (Hospitals And Clinics, Diagnostic Laboratories, Others)- Forecast Till 2027Market HighlightsThe global platelet aggregation devices market held a market value of USD 215.2 million in 2017 and is projected to grow at a CAGR of 20.3% over the forecast period.
Few of the major market growth factors are the globally growing geriatric population coupled with rising prevalence of target diseases, surging number of industry-academia collaborations and clinical studies, and increasing technological advancements in platelet aggregometers such as 96-well plate-based aggregometry.
According to the World Health Organization (WHO), in 2017, the worldwide population aged 60 years and above was 962.0 million, which is projected to increase to more than 2.0 billion by 2050 and further would reach to 3.1 billion by 2100.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7450 Regional AnalysisThe global platelet aggregation devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
This is due to the presence of device manufacturers, rising prevalence of orthopedic, urological, and bleeding disorders, surging number of cardiovascular surgeries, and increasing incidence of blood disorders.
For instance, as per the data provided by the National Hemophilia Foundation, currently, hemophilia A occurs in 1 in 5,000 live male births in US which is about four times as common as hemophilia B.
At present, the number of individuals suffering from hemophilia in the US is around 20,000.Europe is also expected to hold substantial market share over the forecast period due to large population base which is suffering from cardiovascular diseases, neoplasms, and strokes, the domicile of device manufacturers such as Siemens Healthineers, F. Hoffmann-La Roche Ltd, Sentinel CH.
